<li>Honglin Jiang, Ryan K. Muir, Ryan L. Gonciarz, Adam B. Olshen, Iwei Yeh, Byron C. Hann, Ning Zhao, Yung-hua Wang, Spencer C. Behr, James E. Korkola, Michael J. Evans, Eric A. Collisson, Adam R. Renslo. <strong>Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors</strong>. <em>Journal of Experimental Medicine</em>, 2022; 219 (4) DOI: <a href="http://dx.doi.org/10.1084/jem.20210739" rel="nofollow" target="_blank">10.1084/jem.20210739</a>
</li>